IL7 and lymphopenia: Therefore, at day 24, while the patient did not show any improvement in pulmonary function, presented with several intercurrent infections, absence of negativation of SARS-CoV-2 PCR, and marked and persisting lymphopenia, compassionate use of IL-7 was initiated in order to improve immunity and consequently allow viral clearance.